Mohamed S. Abou Donia

Molecular Biology

Former affiliations

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Mohamed S. Abou Donia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished

Investigating the Impact of the Human Gut Microbiome on the Metabolism of Oral Chemotherapeutic Drugs
Abou Donia, M. S.
NJ Commission on Cancer Research
1/1/18 → 12/31/19
Project: Research project
Uncultivated Bacterial Symbionts of Humans: An Untapped Resource for Drug Discovery
Abou Donia, M. S.
NIH NIAID
9/30/15 → 6/30/20
Project: Research project

3106 Citations
23 h-Index
29 Article
5 Review article
2 Chapter
2 Comment/debate
3 More
- 2 Short survey
- 1 Innovation

A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont
Liou, C. S., Sirk, S. J., Diaz, C. A. C., Klein, A. P., Fischer, C. R., Higginbottom, S. K., Erez, A., Donia, M. S., Sonnenburg, J. L. & Sattely, E. S., Feb 20 2020, In : Cell. 180, 4, p. 717-728.e19
Research output: Contribution to journal › Article › peer-review
14 Scopus citations
Correction to: Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome (Metabolomics, (2020), 16, 8, (86), 10.1007/s11306-020-01704-z)
Farag, M. A., Hegazi, N. M. & Donia, M. S., Sep 1 2020, In : Metabolomics. 16, 9, 92.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome
Farag, M. A., Hegazi, N. M. & Donia, M. S., Aug 1 2020, In : Metabolomics. 16, 8, 86.
Research output: Contribution to journal › Article › peer-review
Novel Small Molecule Agent for the Dispersal of Pseudomonas Aeruginosa, and other Type IV Pili Bacteria
Gitai, Z., Scheffler, R., Donia, M. & Sugimoto, Y., Nov 4 2020
Research output: Innovation
Personalized Mapping of Drug Metabolism by the Human Gut Microbiome
Javdan, B., Lopez, J. G., Chankhamjon, P., Lee, Y. C. J., Hull, R., Wu, Q., Wang, X., Chatterjee, S. & Donia, M. S., Jun 25 2020, In : Cell. 181, 7, p. 1661-1679.e22
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations

Investigating the Impact of the Human Gut Microbiome on the Metabolism of Oral Chemotherapeutic Drugs

Uncultivated Bacterial Symbionts of Humans: An Untapped Resource for Drug Discovery

A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont

Correction to: Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome (Metabolomics, (2020), 16, 8, (86), 10.1007/s11306-020-01704-z)

Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome

Novel Small Molecule Agent for the Dispersal of Pseudomonas Aeruginosa, and other Type IV Pili Bacteria

Personalized Mapping of Drug Metabolism by the Human Gut Microbiome